Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases
US9730961B2 · kind B2 · utility
1Cited by
3References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 13, 2015 |
| Grant date | Aug 15, 2017 |
| Priority date | — |
| Expiry date | Oct 15, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2501/48
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention encompasses methods and compositions for treating an ocular disease, disorder or condition in a mammal. The invention includes a population of mesenchymal stromal cells that possess anti-inflammatory, anti-apoptotic, immune modulatory and anti-tumorigenic properties. The invention includes administration of TSG-6, STC-1, or a combination thereof to the ocular as a treatment for an ocular disease, disorder or condition in a mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.